查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1942523

2026年全球心臟瓣膜市场报告

Cardiac Valve Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

心臓弁市场规模は近年急速に拡大しております。2025年の124亿1,000万米ドルから2026年には142亿4,000万米ドルへと、CAGR 14.8％で成长が见込まれております。过去数年间の成长は、心臓弁膜症の発生率上昇、心臓外科プログラムの拡大、人工心臓弁の使用増加、外科的弁置换术の技术の进歩、心臓治疗施设の整备拡大などが要因とされています。

心臓弁市场规模は今后数年间で急速な成长が见込まれます。2030年には240亿2,000万米ドルに达し、CAGRは14.0％となる见込みです。予测期间における成长は、経カテーテル治疗への需要増加、高齢者心臓ケアへの注目の高まり、ハイブリッド心血管手术の拡大、次世代弁技术への投资増加、患者特异性的弁ソリューションの采用拡大に起因すると考えられます。予测期间の主な动向としては、経カテーテル弁置换术の采用増加、生体弁への需要拡大、低侵袭弁置换术の选好度向上、高度な弁修復技术の拡大、弁の耐久性と性能への注目の强化が挙げられます。

心血管疾患の有病率増加が心臓弁市场の成长を牵引する见込みです。吃烟、肥満、运动不足、その他の心血管系への负荷要因が心血管疾患の渐増に寄与しています。动脉内の脂肪性斑块蓄积を特徴とする冠动脉疾患が主な原因の一つです。こうした心臓関连疾患の急増により、心臓弁の问题に対处するための心臓弁への需要が高まっています。2023年9月时点のWHOデータによりますと、心血管疾患は非感染性疾患（NCD）または慢性疾患に関连する全球整体の死亡原因の约74％という大きな割合を占めております。

心臓弁市场における主要企业は、僧帽弁逆流症患者における低侵袭治疗の需要増に対応すべく、経大腿カテーテル僧帽弁置换术（TMVR）システムの开発を进めております。TMVRシステムは、大腿静脉からカテーテルを介して送达される折り畳み式フレームと生体弁叶を使用し、开胸手术を回避するとともに、回復期间と处置リスクを低减します。2025年4月、エドワーズライフサイエンス社はSAPIEN M3システムのCEマーク认证を取得しました。本システムは、安定した弁尖捕捉と精密な生体弁展开を実现するドッキング机构を备え、位置调整や回収を可能にすることで安全性を向上させ、手术やエッジ・トゥ・エッジ修復が仿单标示外となる患者への治疗范囲を拡大します。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球心臟瓣膜市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 工业4.0和智慧製造
    • 数位化、云端运算、巨量资料、网路安全
    • 永续性、气候技术和循环经济
    • 物联网、智慧基础设施和互联生态系统
  • 主要趋势
    • 经导管瓣膜置换术的应用日益广泛
    • 对生物人工心臟瓣膜的需求不断增长
    • 低侵袭弁置换术への选好の高まり
    • 拓展先进阀门维修技术
    • 更加重视阀门的耐久性和性能

第五章 终端用户产业市场分析

  • 医院和诊所
  • 专业心臟中心
  • 心臟研究所
  • 门诊手术中心
  • 教学医院

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球心臟瓣膜市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球心臟瓣膜市场规模、对比及成长率分析
  • 全球心臟瓣膜市场表现：规模与成长，2020-2025年
  • 全球心臟瓣膜市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 按类型
  • 生物人工心臟瓣膜、经​​导管心臟瓣膜、机械心臟瓣膜
  • 按位置
  • 主动脉瓣、二尖瓣及其他部位
  • 透过治疗
  • 心臟瓣膜修復，心臟瓣膜置换
  • 最终用户
  • 医院/诊所、专科医疗中心、心臟研究所和其他最终用户
  • 按类型细分：生物瓣膜
  • 生物瓣膜（例如，猪瓣或牛）、同种异体瓣膜
  • 按类型细分：经导管心臟瓣膜
  • 経カテーテル大动脉弁置换术（TAVR／TAVI）用弁、経カテーテル僧帽弁置换术（TMVR）用弁
  • 按类型细分：机械心臟瓣膜
  • 斜盘阀、双尖阀、笼式球阀

第十章 区域与国家分析

  • 全球心臟瓣膜市场：区域表现及预测，2020-2025年、2025-2030年预测、2035年预测
  • 全球心臟瓣膜市场：国家、市场表现及预测，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 心臟瓣膜市场：竞争格局及市场占有率（2024年）
  • 心臟瓣膜市场：公司估价矩阵
  • 心臟瓣膜市场：公司概况
    • Abbott Laboratories
    • Edwards Lifesciences Corporation
    • Medtronic plc
    • Artivion Inc.
    • Meril Life Sciences Pvt Ltd

第37章：其他领先和创新企业

  • Lepu Medical Technology Co Ltd, TTK Healthcare Limited, Braile Biomedica, JenaValve Technology Inc., Xeltis AG, Colibri Heart Valve LLC, On-X Life Technologies Inc., Thubrikar Aortic Valve Inc., LifeNet Health Inc., Auto Tissue Berlin GmbH, CryoLife Inc., LivaNova PLC, Foldax Inc., Micro Interventional Devices Inc., InnovHeart Srl

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年心臟瓣膜市场：蕴藏新机会的国家
  • 2030年心臟瓣膜市场：充满新机会的细分市场
  • 2030年心臟瓣膜市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME4MCVAL01_G26Q1

Cardiac valves are artificial devices designed to regulate the flow of blood within the heart, ensuring unidirectional blood movement from the heart to other parts of the body. These implantable devices play a crucial role in replacing damaged valves that may have ceased functioning due to various diseases. The primary objective of cardiac valves is to maintain the proper flow of blood through the heart and into the major blood vessels connected to it.

The primary types of cardiac valves include tissue valves, transcatheter valves, mechanical valves, and other variations. Tissue heart valves, utilized in open-heart or minimally invasive surgeries, aim to prevent blood clot formation inside the vessels. These valves are crafted from durable and flexible animal tissue obtained from donors and are employed in cardiac valve repair and replacement procedures. Various positions in the heart, such as the aortic valve and mitral valve, necessitate the repair or replacement of cardiac valves. End-users of cardiac valves include hospitals, clinics, specialty centers, cardiac research institutes, and other healthcare facilities.

Tariffs are influencing the cardiac valve market by increasing costs of imported biomaterials, precision metal components, manufacturing equipment, and sterilization systems used in mechanical and tissue valves. Hospitals and specialty cardiac centers in North America and Europe are most affected due to reliance on imported valve products, while Asia-Pacific faces higher production input costs. These tariffs are raising procedure expenses and procurement budgets. However, they are also supporting domestic valve manufacturing, regional innovation, and localized production of advanced cardiac valve solutions.

The cardiac valve market research report is one of a series of new reports from The Business Research Company that provides cardiac valve market statistics, including cardiac valve industry global market size, regional shares, competitors with a cardiac valve market share, detailed cardiac valve market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac valve industry. This cardiac valve market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cardiac valve market size has grown rapidly in recent years. It will grow from $12.41 billion in 2025 to $14.24 billion in 2026 at a compound annual growth rate (CAGR) of 14.8%. The growth in the historic period can be attributed to rising incidence of valvular heart diseases, expansion of cardiac surgery programs, growing use of mechanical heart valves, advancements in surgical valve techniques, increasing availability of cardiac care facilities.

The cardiac valve market size is expected to see rapid growth in the next few years. It will grow to $24.02 billion in 2030 at a compound annual growth rate (CAGR) of 14.0%. The growth in the forecast period can be attributed to increasing demand for transcatheter interventions, rising focus on elderly cardiac care, expansion of hybrid cardiac procedures, growing investments in next-generation valve technologies, increasing adoption of patient-specific valve solutions. Major trends in the forecast period include increasing adoption of transcatheter valve procedures, rising demand for bioprosthetic heart valves, growing preference for minimally invasive valve replacement, expansion of advanced valve repair techniques, enhanced focus on valve durability and performance.

The increasing prevalence of cardiovascular diseases is poised to drive the growth of the cardiac valve market. Factors such as smoking, obesity, lack of physical activity, and other cardiovascular stressors contribute to a gradual rise in cardiovascular diseases. Coronary artery disease, characterized by the build-up of fatty plaques in arteries, is a common cause. This surge in heart-related ailments has heightened the demand for cardiac valves to address heart valve issues. As of September 2023, data from the World Health Organization indicates that cardiovascular diseases account for a substantial portion, approximately 74%, of global deaths related to non-communicable diseases (NCDs) or chronic conditions.

Major players in the cardiac valve market are advancing transfemoral transcatheter mitral valve replacement (TMVR) systems to address the growing demand for minimally invasive therapies in patients with mitral regurgitation. TMVR systems use collapsible frames and biologic valve leaflets delivered via catheter through the femoral vein, avoiding open-heart surgery and reducing recovery time and procedural risk. In April 2025, Edwards Lifesciences received CE Mark approval for the SAPIEN M3 System, featuring a docking mechanism for stable leaflet capture and precise bioprosthetic valve deployment, enabling repositioning and retrieval to improve safety and expand treatment to patients ineligible for surgery or edge-to-edge repair.

In July 2024, Edwards Lifesciences acquired JenaValve Technology for an upfront USD 500 million, with up to USD 445 million in contingent payments, to expand its cardiac valve portfolio and strengthen its position in aortic regurgitation treatment. The acquisition allows Edwards to integrate JenaValve's Trilogy transcatheter heart valve system, enhancing its offerings in minimally invasive structural heart therapies. JenaValve's expertise in transcatheter valve technologies supports Edwards' strategic growth in high-risk patient populations, reflecting a broader trend in the cardiac device market toward acquisitions that advance portfolio diversification and innovative solutions for complex valve disease.

Major companies operating in the cardiac valve market are Abbott Laboratories, Edwards Lifesciences Corporation, Medtronic plc, Artivion Inc., Meril Life Sciences Pvt Ltd, Lepu Medical Technology Co Ltd, TTK Healthcare Limited, Braile Biomedica, JenaValve Technology Inc., Xeltis AG, Colibri Heart Valve LLC, On-X Life Technologies Inc., Thubrikar Aortic Valve Inc., LifeNet Health Inc., Auto Tissue Berlin GmbH, CryoLife Inc., LivaNova PLC, Foldax Inc., Micro Interventional Devices Inc., InnovHeart Srl

North America was the largest region in the cardiac valve market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac valve market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cardiac valve market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The cardiac valve market consists of sales of tricuspid valves and pulmonary valves. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cardiac Valve Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses cardiac valve market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cardiac valve ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cardiac valve market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Tissue Heart Valves; Transcatheter Heart Valves; Mechanical Heart Valves
  • 2) By Position: Aortic Valve; Mitral Valve; Other Positions
  • 3) By Treatment: Cardiac Valve Repair; Cardiac Valve Replacement
  • 4) By End-Users: Hospital And Clinics; Specialty Centers; Cardiac Research Institute; Other End Users
  • Subsegments:
  • 1) By Tissue Heart Valves: Bioprosthetic Valves (e.g., porcine, bovine); Homograft Valves
  • 2) By Transcatheter Heart Valves: Transcatheter Aortic Valve Replacement (TAVR / TAVI) Valves; Transcatheter Mitral Valve Replacement (TMVR) Valves
  • 3) By Mechanical Heart Valves: Tilting Disc Valves; Bileaflet Valves; Caged Ball Valves
  • Companies Mentioned: Abbott Laboratories; Edwards Lifesciences Corporation; Medtronic plc; Artivion Inc.; Meril Life Sciences Pvt Ltd; Lepu Medical Technology Co Ltd; TTK Healthcare Limited; Braile Biomedica; JenaValve Technology Inc.; Xeltis AG; Colibri Heart Valve LLC; On-X Life Technologies Inc.; Thubrikar Aortic Valve Inc.; LifeNet Health Inc.; Auto Tissue Berlin GmbH; CryoLife Inc.; LivaNova PLC; Foldax Inc.; Micro Interventional Devices Inc.; InnovHeart Srl
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Cardiac Valve Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Cardiac Valve Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Cardiac Valve Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Cardiac Valve Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Industry 4.0 & Intelligent Manufacturing
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Sustainability, Climate Tech & Circular Economy
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Transcatheter Valve Procedures
    • 4.2.2 Rising Demand For Bioprosthetic Heart Valves
    • 4.2.3 Growing Preference For Minimally Invasive Valve Replacement
    • 4.2.4 Expansion Of Advanced Valve Repair Techniques
    • 4.2.5 Enhanced Focus On Valve Durability And Performance

5. Cardiac Valve Market Analysis Of End Use Industries

  • 5.1 Hospitals And Clinics
  • 5.2 Specialty Cardiac Centers
  • 5.3 Cardiac Research Institutes
  • 5.4 Ambulatory Surgical Centers
  • 5.5 Teaching Hospitals

6. Cardiac Valve Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Cardiac Valve Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Cardiac Valve PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Cardiac Valve Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Cardiac Valve Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Cardiac Valve Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Cardiac Valve Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Cardiac Valve Market Segmentation

  • 9.1. Global Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Tissue Heart Valves, Transcatheter Heart Valves, Mechanical Heart Valves
  • 9.2. Global Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Aortic Valve, Mitral Valve, Other Positions
  • 9.3. Global Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cardiac Valve Repair, Cardiac Valve Replacement
  • 9.4. Global Cardiac Valve Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospital And Clinics, Specialty Centers, Cardiac Research Institute, Other End Users
  • 9.5. Global Cardiac Valve Market, Sub-Segmentation Of Tissue Heart Valves, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Bioprosthetic Valves (e.g., porcine, bovine), Homograft Valves
  • 9.6. Global Cardiac Valve Market, Sub-Segmentation Of Transcatheter Heart Valves, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Transcatheter Aortic Valve Replacement (TAVR / TAVI) Valves, Transcatheter Mitral Valve Replacement (TMVR) Valves
  • 9.7. Global Cardiac Valve Market, Sub-Segmentation Of Mechanical Heart Valves, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Tilting Disc Valves, Bileaflet Valves, Caged Ball Valves

10. Cardiac Valve Market Regional And Country Analysis

  • 10.1. Global Cardiac Valve Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Cardiac Valve Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Cardiac Valve Market

  • 11.1. Asia-Pacific Cardiac Valve Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Cardiac Valve Market, Segmentation By Type, Segmentation By Position, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Cardiac Valve Market

  • 12.1. China Cardiac Valve Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Cardiac Valve Market, Segmentation By Type, Segmentation By Position, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Cardiac Valve Market

  • 13.1. India Cardiac Valve Market, Segmentation By Type, Segmentation By Position, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Cardiac Valve Market

  • 14.1. Japan Cardiac Valve Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Cardiac Valve Market, Segmentation By Type, Segmentation By Position, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Cardiac Valve Market

  • 15.1. Australia Cardiac Valve Market, Segmentation By Type, Segmentation By Position, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Cardiac Valve Market

  • 16.1. Indonesia Cardiac Valve Market, Segmentation By Type, Segmentation By Position, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Cardiac Valve Market

  • 17.1. South Korea Cardiac Valve Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Cardiac Valve Market, Segmentation By Type, Segmentation By Position, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Cardiac Valve Market

  • 18.1. Taiwan Cardiac Valve Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Cardiac Valve Market, Segmentation By Type, Segmentation By Position, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Cardiac Valve Market

  • 19.1. South East Asia Cardiac Valve Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Cardiac Valve Market, Segmentation By Type, Segmentation By Position, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Cardiac Valve Market

  • 20.1. Western Europe Cardiac Valve Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Cardiac Valve Market, Segmentation By Type, Segmentation By Position, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Cardiac Valve Market

  • 21.1. UK Cardiac Valve Market, Segmentation By Type, Segmentation By Position, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Cardiac Valve Market

  • 22.1. Germany Cardiac Valve Market, Segmentation By Type, Segmentation By Position, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Cardiac Valve Market

  • 23.1. France Cardiac Valve Market, Segmentation By Type, Segmentation By Position, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Cardiac Valve Market

  • 24.1. Italy Cardiac Valve Market, Segmentation By Type, Segmentation By Position, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Cardiac Valve Market

  • 25.1. Spain Cardiac Valve Market, Segmentation By Type, Segmentation By Position, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Cardiac Valve Market

  • 26.1. Eastern Europe Cardiac Valve Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Cardiac Valve Market, Segmentation By Type, Segmentation By Position, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Cardiac Valve Market

  • 27.1. Russia Cardiac Valve Market, Segmentation By Type, Segmentation By Position, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Cardiac Valve Market

  • 28.1. North America Cardiac Valve Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Cardiac Valve Market, Segmentation By Type, Segmentation By Position, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Cardiac Valve Market

  • 29.1. USA Cardiac Valve Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Cardiac Valve Market, Segmentation By Type, Segmentation By Position, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Cardiac Valve Market

  • 30.1. Canada Cardiac Valve Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Cardiac Valve Market, Segmentation By Type, Segmentation By Position, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Cardiac Valve Market

  • 31.1. South America Cardiac Valve Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Cardiac Valve Market, Segmentation By Type, Segmentation By Position, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Cardiac Valve Market

  • 32.1. Brazil Cardiac Valve Market, Segmentation By Type, Segmentation By Position, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Cardiac Valve Market

  • 33.1. Middle East Cardiac Valve Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Cardiac Valve Market, Segmentation By Type, Segmentation By Position, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Cardiac Valve Market

  • 34.1. Africa Cardiac Valve Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Cardiac Valve Market, Segmentation By Type, Segmentation By Position, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Cardiac Valve Market Regulatory and Investment Landscape

36. Cardiac Valve Market Competitive Landscape And Company Profiles

  • 36.1. Cardiac Valve Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Cardiac Valve Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Cardiac Valve Market Company Profiles
    • 36.3.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Edwards Lifesciences Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Artivion Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Meril Life Sciences Pvt Ltd Overview, Products and Services, Strategy and Financial Analysis

37. Cardiac Valve Market Other Major And Innovative Companies

  • Lepu Medical Technology Co Ltd, TTK Healthcare Limited, Braile Biomedica, JenaValve Technology Inc., Xeltis AG, Colibri Heart Valve LLC, On-X Life Technologies Inc., Thubrikar Aortic Valve Inc., LifeNet Health Inc., Auto Tissue Berlin GmbH, CryoLife Inc., LivaNova PLC, Foldax Inc., Micro Interventional Devices Inc., InnovHeart Srl

38. Global Cardiac Valve Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Cardiac Valve Market

40. Cardiac Valve Market High Potential Countries, Segments and Strategies

  • 40.1 Cardiac Valve Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Cardiac Valve Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Cardiac Valve Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer